Search company, investor...
Search

Founded Year

2016

Stage

Series A | Alive

Total Raised

$10M

Last Raised

$10M | 3 yrs ago

About DotLab

DotLab is developing a non-invasive test for endometriosis.

DotLab Headquarters Location

505 Montgomery St Floor 11

San Francisco, California, 94111,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

DotLab's Products & Differentiation

See DotLab's products and how their products differentiate from alternatives and competitors

  • DotEndo

    DotEndo is harnessing DotLab's expertise with novel, cutting-edge biomarkers and the power of machine learning to deliver the first non-invasive tool to diagnose endometriosis, resulting in a paradigm shift in the identification and management of the disease.

Expert Collections containing DotLab

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

DotLab is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Latest DotLab News

DotLab Is Granted Patents for DotEndo, Its Non-invasive Endometriosis Test

Aug 22, 2022

Medical diagnostics company DotLab has been granted three patents by the United States Patent and Trademark Office for its technology focused on the diagnosis, assessment, and characterization of endometriosis. Via its clinical studies, DotLab has pioneered medical tests enabled by single-stranded, non-coding RNAs called microRNAs in circulating body fluids such as blood and saliva. The inventions embodied in the portfolio of granted…

DotLab Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

DotLab Rank

  • When was DotLab founded?

    DotLab was founded in 2016.

  • Where is DotLab's headquarters?

    DotLab's headquarters is located at 505 Montgomery St, San Francisco.

  • What is DotLab's latest funding round?

    DotLab's latest funding round is Series A.

  • How much did DotLab raise?

    DotLab raised a total of $10M.

  • Who are the investors of DotLab?

    Investors of DotLab include Tiger Global Management, Cooper Surgical, Luxor Capital Group, Berkeley SkyDeck and Yale University.

  • Who are DotLab's competitors?

    Competitors of DotLab include NextGen Jane and 1 more.

  • What products does DotLab offer?

    DotLab's products include DotEndo.

You May Also Like

A
AbbVie

AbbVie (NYSE: ABBV) consists of scientists, researchers, communicators, manufacturing specialists, and regulatory professionals who seek to come up with new approaches to addressing today's health issues-from life-threatening illness to chronic conditions. The company focuses its R&D efforts and technology investments to pursue this goal.

N
NextGen Jane

NextGen Jane offers women insights into their reproductive health through a genomics-driven approach to tracking biological changes predictive of disease. Its smart tampon allows women to proactively keep track of their health by studying blood samples in the privacy of their homes. The company was founded in 2014 and is based in Oakland, California.

T
Temple Therapeutics

Temple Therapeutics is a pharmaceutical clinical development company with a global footprint, focused on diseases where abnormal tissue growth and dysfunction are common hallmarks and lead to fibrosis, pain, infertility, and cancers. The company was founded in 2020 and is based in Geleen, Netherlands.

Baxter International Logo
Baxter International

Baxter International (NYSE: BAX) is an American healthcare company that provides a broad portfolio of essential renal and hospital products, including home, acute, and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software, and services. The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders, and other chronic and acute medical conditions.

Cheetah Medical Logo
Cheetah Medical

Cheetah Medical is a provider in non-invasive Cardiac Output and Hemodynamic monitoring. The company is focused on development and commercialization of an accurate non-invasive solution for the monitoring of critically ill patients. Cheetah Medical's NICOM Noninvasive Hemodynamic Monitoring System is based on the company's BIOREACTANCE technology.On September 10, 2019, Cheetah Medical was acquired by Baxter at a valuation of between $190M and $230M.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.